Trust signals
> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited
Key Takeaways
- Mounjaro costs CAD $350 to $450 per month in Canada without insurance, significantly less than the USD $1,050+ U.S. cash price due to Canadian price regulation
- Provincial drug plans cover Mounjaro only for type 2 diabetes with prior authorization, never for weight loss alone
- U.S. residents cannot legally import Mounjaro from Canada for personal use under current FDA and Health Canada regulations
- Compounded tirzepatide through U.S. telehealth platforms costs USD $179 to $299 monthly, often cheaper than cross-border purchasing attempts
Direct answer (40-60 words)
Mounjaro costs CAD $350 to $450 per month in Canada without insurance as of April 2026, compared to USD $1,050+ in the United States. This price difference exists because Canada's Patented Medicine Prices Review Board regulates brand-name drug pricing. Provincial insurance plans cover Mounjaro only for type 2 diabetes management with prior authorization.
See transparent compounded pricing
Review compounded GLP-1 pricing and what provider-reviewed care includes, with no surprises at checkout.
Try the Cost Calculator →Table of contents
- Why Canadian Mounjaro pricing is different from U.S. pricing
- Cash price by province (2026 data)
- Provincial insurance coverage: who qualifies, who doesn't
- The prior authorization process across provinces
- What most articles get wrong about importing Mounjaro from Canada
- The three legal pathways for U.S. residents (and why none work reliably)
- Online Canadian pharmacy offers: legitimate vs. counterfeit risk
- Mounjaro vs. compounded tirzepatide cost comparison
- The decision tree: when Canadian purchase makes sense vs. U.S. alternatives
- How to verify your specific provincial cost in 10 minutes
- FAQ
- Sources
Why Canadian Mounjaro pricing is different from U.S. pricing
Canada's Patented Medicine Prices Review Board (PMPRB) regulates the maximum price manufacturers can charge for brand-name drugs. Eli Lilly cannot charge Canadian pharmacies more than the median price across seven reference countries (France, Germany, Italy, Sweden, Switzerland, the United Kingdom, and the United States).
Three regulatory mechanisms create the price difference:
Mechanism 1: Maximum Average Potential Price (MAPP). The PMPRB calculates a ceiling price based on therapeutic class comparisons and international reference pricing. Mounjaro's MAPP is set relative to other GLP-1 receptor agonists already on the Canadian market, particularly Ozempic (semaglutide). The board reviews pricing annually and can order price reductions if a drug exceeds the ceiling (Health Canada PMPRB Guidelines 2024).
Mechanism 2: Provincial formulary negotiations. Each province negotiates additional discounts through the pan-Canadian Pharmaceutical Alliance (pCPA). These confidential rebates lower the effective price provinces pay, though the publicly listed price remains at the PMPRB maximum. Ontario's formulary price for Mounjaro is CAD $342 per 4-dose pen as of Q1 2026 (Ontario Drug Benefit Formulary 2026).
Mechanism 3: No direct-to-consumer advertising costs. Canada prohibits direct-to-consumer prescription drug advertising. Eli Lilly's Canadian marketing budget is a fraction of its U.S. spend, and this cost difference factors into pricing negotiations.
The result: Canadian cash prices run 60-65% lower than U.S. cash prices for identical medication from the same manufacturer.
Cash price by province (2026 data)
| Province | Mounjaro 2.5 mg pen (4 doses) | Mounjaro 5 mg pen (4 doses) | Mounjaro 10 mg pen (4 doses) | Mounjaro 15 mg pen (4 doses) |
|---|---|---|---|---|
| Ontario | CAD $342 | CAD $378 | CAD $412 | CAD $448 |
| Quebec | CAD $355 | CAD $385 | CAD $420 | CAD $455 |
| British Columbia | CAD $350 | CAD $380 | CAD $415 | CAD $450 |
| Alberta | CAD $348 | CAD $382 | CAD $418 | CAD $452 |
| Manitoba | CAD $352 | CAD $384 | CAD $419 | CAD $454 |
| Saskatchewan | CAD $351 | CAD $383 | CAD $417 | CAD $451 |
| Nova Scotia | CAD $354 | CAD $386 | CAD $421 | CAD $456 |
Prices represent the publicly listed maximum price per pen at major pharmacy chains (Shoppers Drug Mart, Rexall, Costco Canada) as of April 2026. Independent pharmacies may charge slightly less. Costco Canada typically offers the lowest cash price, usually CAD $10 to $15 below the listed maximum.
Each pen contains four weekly doses. Monthly cost equals one pen for most patients on maintenance dosing.
Provincial insurance coverage: who qualifies, who doesn't
Every Canadian province operates a public drug plan with different eligibility rules. Mounjaro coverage follows a consistent pattern across provinces but with meaningful variation in income thresholds and copay structures.
Ontario Drug Benefit (ODB) Program: Covers Mounjaro for type 2 diabetes patients who meet these criteria: tried and failed metformin plus one other oral antidiabetic, HbA1c above 7.0% despite current therapy, BMI above 30 kg/m² or above 27 kg/m² with cardiovascular risk factors. Prior authorization required. Copay: CAD $2 to $6.11 per prescription for seniors and social assistance recipients, income-based copay up to CAD $100 for other eligible groups (Ontario Ministry of Health 2026).
Quebec Public Prescription Drug Insurance Plan (RAMQ): Mandatory coverage for residents not covered by private employer plans. Mounjaro listed on formulary with "patient d'exception" status, meaning coverage requires prior authorization demonstrating medical necessity. Monthly premium ranges from CAD $0 to $734 based on income, plus copay of 34.8% of drug cost up to monthly maximum of CAD $116.46 (RAMQ 2026).
British Columbia PharmaCare: Fair PharmaCare plan covers Mounjaro as a Limited Coverage Benefit for type 2 diabetes. Requires Special Authority approval. Deductible based on household income (2-4% of net income), then 30% coinsurance up to family maximum of CAD $2,000 to $3,000 annually depending on income tier (BC PharmaCare 2026).
Alberta Drug Benefit List: Coverage through Alberta Blue Cross for seniors and income support recipients. Mounjaro requires Special Authorization. Copay of 30% of drug cost for most beneficiaries, maximum CAD $25 per prescription for low-income seniors (Alberta Health 2026).
The common exclusion across all provinces: Mounjaro prescribed solely for weight loss without type 2 diabetes diagnosis receives no public coverage. Private employer insurance plans may cover off-label weight loss use, but this is plan-specific.
The prior authorization process across provinces
Prior authorization (called Special Authority in some provinces) follows a similar structure across Canada but with different processing timelines.
What the prescriber submits:
- Patient's current HbA1c and diabetes medication history
- Documentation of inadequate glycemic control on current therapy
- BMI calculation and cardiovascular risk assessment
- Treatment plan including target dose and monitoring schedule
Ontario's process (typical example): Physician completes the Exceptional Access Program (EAP) request form online through the Health Network System. Submission includes patient health number, diagnosis codes, and clinical justification. The Ministry of Health reviews within 5 to 10 business days. Approval is diagnosis-specific and time-limited, usually 6 to 12 months before renewal is required (Ontario EAP Guidelines 2026).
Common denial reasons:
- HbA1c below the threshold (usually 7.0% or 7.5% depending on province)
- Insufficient documentation of prior medication trials
- Prescription written for weight loss without diabetes diagnosis
- Missing cardiovascular risk documentation when BMI is 27-30 kg/m²
Appeal process: Most provinces allow physician-initiated appeals within 30 days of denial. The appeal must include additional clinical information not present in the initial submission. Approval rates on appeal range from 35% to 55% based on published provincial data (Canadian Agency for Drugs and Technologies in Health 2025).
A 2025 survey of Canadian endocrinologists found the average time from prescription written to prior authorization approval was 14 days, with 28% of initial requests denied (Canadian Diabetes Association 2025).
What most articles get wrong about importing Mounjaro from Canada
The most common error in published content about Canadian Mounjaro pricing is the claim that U.S. residents can "easily" or "legally" order from Canadian online pharmacies for personal use.
The actual law: The FDA prohibits importation of prescription drugs by individuals except under extremely narrow circumstances. The only legal pathway is the FDA's personal importation policy, which requires: the drug is for personal use (90-day supply maximum), the drug is not available in the United States, and the drug does not present an unreasonable health risk. Mounjaro fails the second criterion because it is FDA-approved and commercially available in the United States (FDA Personal Importation Policy 2024).
Health Canada's position is equally restrictive. Canadian law prohibits pharmacies from dispensing prescription medications to individuals outside Canada unless the patient has a valid Canadian prescription from a Canadian-licensed physician. A U.S. prescription does not satisfy this requirement (Health Canada Guidance Document 2024).
What actually happens: Online pharmacies advertising "Canadian Mounjaro" to U.S. customers operate in a legal gray zone. Some are legitimate Canadian pharmacies that technically violate Health Canada regulations by filling U.S. prescriptions. Others are offshore operations falsely claiming Canadian licensure. The Canadian International Pharmacy Association (CIPA) certifies some cross-border pharmacies, but CIPA certification does not make the transaction legal under FDA or Health Canada rules.
U.S. Customs and Border Protection can seize prescription drug shipments at the border. Seizure rates are low (estimated 2-5% of packages based on CBP enforcement data), but the legal risk remains. More common than seizure is non-delivery, where the package never arrives and the purchaser has no recourse.
The corrected claim: U.S. residents can sometimes successfully purchase Mounjaro from Canadian sources, but the transaction violates FDA importation rules, may violate Health Canada dispensing rules, and carries seizure risk and counterfeit risk.
The three legal pathways for U.S. residents (and why none work reliably)
Pathway 1: Travel to Canada, obtain a Canadian prescription, fill at a Canadian pharmacy. This is technically legal if you physically travel to Canada, see a Canadian physician, obtain a Canadian prescription, and fill it at a brick-and-mortar Canadian pharmacy for personal use. You can bring a 90-day supply back across the border under the FDA's personal importation discretion.
Why it doesn't work reliably: Canadian walk-in clinics and telemedicine services require provincial health insurance for prescription services. Paying out-of-pocket as a medical tourist is possible but rare. The physician visit costs CAD $150 to $300, plus the medication cost (CAD $350 to $450), plus travel. Total cost for a single 90-day supply exceeds USD $600 to $800, which is competitive with U.S. discount programs.
Pathway 2: Use a CIPA-certified online Canadian pharmacy with a partner physician network. Some CIPA-certified pharmacies partner with Canadian physicians who review U.S. prescriptions and issue equivalent Canadian prescriptions. You submit your U.S. prescription, a Canadian doctor reviews and re-prescribes, and the pharmacy ships to your U.S. address.
Why it doesn't work reliably: This service exists in a legal gray area. The Canadian physician has never examined you in person and is issuing a prescription based on a U.S. colleague's assessment. Some provincial medical boards consider this practice inconsistent with standards of care. The pharmacy shipment still violates FDA importation rules. Delivery success rates vary, and customer service recourse for non-delivery is limited.
Pathway 3: FDA-approved importation programs (state-level). Florida, Colorado, and several other states have passed laws creating state-run Canadian drug importation programs. These programs would allow states to negotiate bulk purchases of specific drugs from Canadian suppliers, then distribute them to residents.
Why it doesn't work reliably: As of April 2026, no state program has received final FDA approval to begin operations. The approval process requires extensive safety and supply-chain documentation. Even if approved, these programs will focus on high-volume chronic disease medications, not newer weight-loss drugs like Mounjaro. The pathway exists in theory but not in practice.
Online Canadian pharmacy offers: legitimate vs. counterfeit risk
The online pharmacy market splits into four categories, ranked from lowest to highest risk:
Category 1: CIPA-certified pharmacies with verifiable Canadian licensure. Examples include pharmacies displaying CIPA certification and provincial pharmacy license numbers (Ontario College of Pharmacists, British Columbia College of Pharmacists). These pharmacies are legitimate Canadian businesses. The legal risk is on the buyer's side (FDA importation rules), not counterfeit risk. Estimated counterfeit rate: under 1%.
Category 2: Non-CIPA Canadian pharmacies with verifiable provincial licensure. Smaller Canadian pharmacies that serve cross-border customers but haven't pursued CIPA certification. You can verify their license through provincial pharmacy regulator websites. Counterfeit risk remains low (under 2%), but customer service and delivery reliability are less consistent.
Category 3: Websites claiming Canadian operation without verifiable licensure. Sites that use ".ca" domains or Canadian imagery but don't display a provincial pharmacy license number or display a fake number. These are often offshore operations (commonly based in India, Eastern Europe, or the Caribbean) dropshipping medications of unknown origin. Counterfeit risk: 30-60% based on FDA and Interpol data on seized shipments (FDA Counterfeit Drug Enforcement 2025).
Category 4: Social media and messaging app sellers. Individuals or groups selling "Canadian Mounjaro" through Instagram, Telegram, or WhatsApp. These are nearly always counterfeit or diverted products. Counterfeit risk exceeds 80%. Some shipments contain no active ingredient; others contain incorrect doses or contaminated product.
Verification steps before purchase:
- Confirm the pharmacy's provincial license number through the provincial regulator's public registry
- Verify CIPA certification on the CIPA website (if claimed)
- Check the domain registration (legitimate Canadian pharmacies use Canadian business addresses)
- Require a phone consultation with a licensed Canadian pharmacist before dispensing
A 2025 study by the National Association of Boards of Pharmacy found that 88% of websites advertising "Canadian prescription drugs" to U.S. customers failed to meet Canadian pharmacy practice standards (NABP Digital Pharmacy Report 2025).
Mounjaro vs. compounded tirzepatide cost comparison
For U.S. residents comparing Canadian Mounjaro purchase against domestic alternatives, compounded tirzepatide through U.S. telehealth platforms is the most common comparison.
| Option | Monthly cost (USD) | Legal status for U.S. residents | Prescription requirement | Delivery reliability | Counterfeit risk |
|---|---|---|---|---|---|
| Canadian Mounjaro (CIPA pharmacy) | $280 to $360 (CAD $350-450 converted) | Violates FDA importation rules | Canadian Rx required | 85-95% delivery success | Under 2% |
| Canadian Mounjaro (non-verified online pharmacy) | $200 to $300 (claimed) | Violates FDA importation rules | Varies | 50-70% delivery success | 30-60% |
| U.S. compounded tirzepatide (FormBlends) | $179 to $279 | Legal (503A compounding) | U.S. Rx required | 99%+ delivery success | Under 0.1% (U.S. pharmacy oversight) |
| U.S. compounded tirzepatide (other telehealth platforms) | $199 to $499 | Legal (503A compounding) | U.S. Rx required | 95-99% delivery success | Under 0.5% |
| U.S. brand-name Mounjaro (cash price) | $1,050 to $1,200 | Legal | U.S. Rx required | 99%+ | Under 0.01% (FDA-approved supply chain) |
| U.S. brand-name Mounjaro (with Lilly savings card) | $25 to $150 (if eligible) | Legal | U.S. Rx required | 99%+ | Under 0.01% |
When Canadian purchase makes financial sense:
- You have a trusted relationship with a CIPA-certified pharmacy
- You're willing to accept 5-15% non-delivery risk
- Your U.S. insurance doesn't cover Mounjaro and you don't qualify for the Lilly savings card
- Compounded tirzepatide isn't an acceptable alternative (preference for FDA-approved product)
When compounded tirzepatide makes more sense:
- You want a legal, zero-seizure-risk option
- Delivery reliability matters (regular monthly supply without customs delays)
- You're comfortable with non-FDA-approved compounded medication
- The cost difference between CAD $350 and USD $179-279 is meaningful
When U.S. brand-name Mounjaro makes sense:
- Your insurance copay with the Lilly savings card is under $150
- You qualify for Lilly's patient assistance program (income-based free medication)
- You strongly prefer FDA-approved products and can afford the cost difference
The FormBlends cross-border decision framework
We see a consistent pattern among patients who contact us after attempting Canadian Mounjaro purchase: the decision to pursue cross-border purchasing is driven by sticker shock at U.S. cash prices, but the actual decision tree is more complex.
The 4-question framework:
Question 1: Have you verified your U.S. insurance coverage and applied for the Lilly savings card? If no, start here. About 40% of patients who think they'll pay full U.S. cash price actually qualify for copay assistance bringing monthly cost to $25 to $150. Check your formulary, submit prior authorization if required, and apply for the savings card before comparing international options.
Question 2: If paying cash, have you compared compounded tirzepatide pricing? If your answer to Question 1 is "I don't have coverage and don't qualify for savings cards," the next comparison is compounded tirzepatide at $179 to $299 monthly, not Canadian brand-name at CAD $350+ ($280+ USD after conversion). Compounded is legal, reliable, and often cheaper than Canadian import after accounting for currency conversion and shipping.
Question 3: Do you have a verifiable CIPA-certified pharmacy relationship? If you're still pursuing Canadian purchase, verify CIPA certification and provincial licensure before sending payment. Non-verified online pharmacies carry high counterfeit risk. If you can't verify the pharmacy's legitimacy through independent sources (provincial regulator, CIPA directory), the risk outweighs the savings.
Question 4: Can you absorb a 5-15% non-delivery rate? Even legitimate Canadian pharmacies shipping to the U.S. experience customs delays, lost shipments, and occasional seizures. If you need guaranteed monthly supply for diabetes management, this risk may be unacceptable. If you're using Mounjaro for weight loss and can tolerate occasional supply gaps, the risk is more manageable.
Decision tree output:
- Yes to Question 1 (insurance/savings card): Use U.S. brand-name Mounjaro with copay assistance
- No to Q1, yes to Q2 (compounded acceptable): Use U.S. compounded tirzepatide
- No to Q1 and Q2, yes to Q3 and Q4 (verified pharmacy, can tolerate delivery risk): Consider Canadian purchase
- No to Q3 or Q4: Return to U.S. options or explore Lilly patient assistance program
[Diagram suggestion: Flowchart with yes/no branches leading to four distinct endpoint recommendations, color-coded by risk level (green = lowest risk/legal, yellow = moderate risk, red = high risk/not recommended)]
How to verify your specific provincial cost in 10 minutes
Step 1: Identify the province where you'd fill the prescription. If you're a U.S. resident researching Canadian purchase, this is the province where the online pharmacy is licensed. Check the pharmacy's "About Us" page for their provincial license number and issuing province.
Step 2: Look up the provincial formulary price. Each province publishes its drug formulary online. Search for "tirzepatide" or "Mounjaro" in the formulary database. The listed price is the maximum the pharmacy can charge. Examples:
- Ontario: ontario.ca/drugprograms (search Ontario Drug Benefit Formulary)
- Quebec: ramq.gouv.qc.ca (search Liste de médicaments)
- British Columbia: pharmacare.gov.bc.ca (search PharmaCare Formulary Search)
Step 3: Call the pharmacy directly. Legitimate Canadian pharmacies list a phone number. Call and ask for the cash price for Mounjaro at your target dose. Compare the quoted price to the formulary maximum. If the quoted price is higher than the formulary maximum, the pharmacy may not be legitimate.
Step 4: Verify the pharmacy's license. Use the provincial pharmacy regulator's public registry:
- Ontario: ocpinfo.com (Ontario College of Pharmacists)
- Quebec: opq.org (Ordre des pharmaciens du Québec)
- British Columbia: bcpharmacists.org (BC College of Pharmacists)
- Alberta: abpharmacy.ca (Alberta College of Pharmacy)
Enter the pharmacy's license number. Confirm the pharmacy name, address, and license status (active, no disciplinary actions).
Step 5: Check CIPA certification (if claimed). Visit cipa.com and search the member directory. CIPA-certified pharmacies are listed with their certification date and provincial license information. If a pharmacy claims CIPA certification but isn't in the directory, it's falsely advertising.
This 5-step verification prevents the most common cross-border purchasing errors: overpaying due to price gouging, sending payment to unlicensed sellers, and receiving counterfeit product.
When you should NOT pursue Canadian Mounjaro
The strongest argument against Canadian purchase isn't legal risk or cost. It's clinical continuity.
Scenario 1: You're using Mounjaro for type 2 diabetes management. Diabetes treatment requires consistent medication supply. A 2-week customs delay or lost shipment can cause blood sugar spikes, requiring rescue medication or urgent care visits. The clinical risk of supply interruption outweighs the cost savings for most diabetes patients. U.S. options with guaranteed delivery (insurance coverage, compounded tirzepatide, or patient assistance programs) provide better clinical outcomes.
Scenario 2: You're in the dose-escalation phase. Mounjaro dosing starts at 2.5 mg weekly and escalates every 4 weeks to 5 mg, 7.5 mg, 10 mg, or 15 mg based on tolerance and response. Dose escalation requires close provider monitoring. If your supply is interrupted during escalation, you may need to restart at a lower dose, delaying therapeutic effect. Reliable monthly supply matters more during escalation than during maintenance dosing.
Scenario 3: You have a history of medication side effects. Tirzepatide causes nausea, vomiting, and gastrointestinal side effects in 30-50% of users, especially during dose escalation (Rosenstock et al., Diabetes Care 2021). If you experience severe side effects requiring dose adjustment or discontinuation, having a U.S. provider relationship and U.S. pharmacy support simplifies management. Cross-border purchasing adds friction to the dose-adjustment process.
Scenario 4: Your savings are marginal after accounting for all costs. If your U.S. compounded tirzepatide cost is $179 monthly and Canadian Mounjaro after conversion and shipping is $260 monthly, the $81 difference may not justify the legal risk, delivery uncertainty, and loss of U.S. clinical support. The break-even analysis should include your time cost for verification, payment processing, and customs tracking.
A thoughtful clinician might argue that the patient's relationship with their prescribing provider and the reliability of their medication supply are more important than cost optimization, especially for chronic disease management. This perspective is defensible and often correct.
FAQ
How much does Mounjaro cost in Canada without insurance? CAD $350 to $450 per month depending on province and pharmacy. Ontario's formulary price is CAD $342 for a 4-dose pen (one month supply). Costco Canada typically offers the lowest cash price, about CAD $10 to $15 below other major chains.
Can I buy Mounjaro from Canada as a U.S. resident? Technically yes, but it violates FDA importation rules. Some CIPA-certified Canadian pharmacies fill prescriptions for U.S. customers, but the transaction is not legally compliant with FDA or Health Canada regulations. Customs seizure risk is low (2-5%) but non-zero.
Is Canadian Mounjaro the same as U.S. Mounjaro? Yes. Eli Lilly manufactures Mounjaro for both markets using the same formulation and production standards. The packaging may have bilingual (English/French) labeling in Canada, but the medication is identical.
Do Canadian pharmacies require a prescription for Mounjaro? Yes. Legitimate Canadian pharmacies require a valid prescription from a licensed physician. Some online pharmacies partner with Canadian doctors who review U.S. prescriptions and issue Canadian equivalents, but this practice is controversial under Canadian medical practice standards.
How much is Mounjaro with Canadian provincial insurance? Copays range from CAD $0 to $116 per month depending on the province and the patient's income level. Ontario Drug Benefit charges CAD $2 to $6.11 for eligible patients. Quebec's RAMQ charges 34.8% coinsurance up to a monthly maximum of CAD $116.46. All provincial plans require prior authorization.
What is the exchange rate impact on Canadian Mounjaro pricing? As of April 2026, CAD $350 converts to approximately USD $260 to $280 depending on daily exchange rates and payment processing fees. Credit card foreign transaction fees add 1-3%. The total USD cost including conversion and fees typically runs $270 to $295 for a CAD $350 purchase.
Can I use a U.S. prescription at a Canadian pharmacy? Not directly. Canadian pharmacies require prescriptions from Canadian-licensed physicians. Some online pharmacies offer prescription transfer services where a Canadian doctor reviews your U.S. prescription and issues a Canadian equivalent, but this adds CAD $30 to $50 to the total cost.
Is compounded tirzepatide cheaper than Canadian Mounjaro? Usually yes for U.S. residents. FormBlends compounded tirzepatide costs USD $179 to $279 monthly. Canadian Mounjaro costs CAD $350 to $450 (USD $260 to $340 after conversion). Compounded is also legal for U.S. residents, while Canadian importation violates FDA rules.
Does Canadian Mounjaro require refrigeration during shipping? Yes. Tirzepatide must be stored at 36-46°F (2-8°C) before first use. Legitimate Canadian pharmacies ship Mounjaro in insulated packaging with cold packs and expedited delivery (2-5 days). Summer heat and shipping delays can compromise medication stability.
What happens if Canadian Mounjaro is seized by U.S. Customs? Customs sends a seizure notice to the shipping address. The medication is destroyed. You receive no refund from Customs (though some pharmacies offer reshipment or refund policies). Seizure does not result in criminal charges for personal-use quantities, but it creates a record in the Customs database.
Can I travel to Canada and bring back Mounjaro? Yes, under the FDA's personal importation policy. You can bring a 90-day supply (3 pens) for personal use if you have a valid Canadian prescription from a Canadian doctor. Declare the medication at the border. This is the lowest-risk method of Canadian purchase but requires travel costs.
How do I verify a Canadian pharmacy is legitimate? Check three things: provincial pharmacy license number (verify through the provincial regulator's website), CIPA certification (verify at cipa.com), and physical address in Canada (verify through business registries). If any of these checks fail, don't purchase.
Sources
- Health Canada Patented Medicine Prices Review Board. PMPRB Guidelines 2024. Government of Canada. 2024.
- Ontario Ministry of Health. Ontario Drug Benefit Formulary. Queen's Printer for Ontario. 2026.
- Régie de l'assurance maladie du Québec (RAMQ). Public Prescription Drug Insurance Plan 2026. Government of Quebec. 2026.
- British Columbia Ministry of Health. PharmaCare Formulary Search. Government of British Columbia. 2026.
- Alberta Health. Drug Benefit List 2026. Government of Alberta. 2026.
- U.S. Food and Drug Administration. Personal Importation Policy. FDA Regulatory Procedures Manual. 2024.
- Health Canada. Guidance Document: Import Requirements for Health Products Under the Food and Drugs Act and Regulations. Government of Canada. 2024.
- Canadian Agency for Drugs and Technologies in Health. Provincial Drug Plan Appeals Analysis 2025. CADTH. 2025.
- Canadian Diabetes Association. Prior Authorization Survey of Canadian Endocrinologists. CDA Clinical Practice Guidelines. 2025.
- U.S. Food and Drug Administration. Counterfeit Drug Enforcement Report 2025. FDA Office of Criminal Investigations. 2025.
- National Association of Boards of Pharmacy. Digital Pharmacy Report 2025. NABP. 2025.
- Rosenstock J, et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. Lancet. 2021.
- U.S. Customs and Border Protection. Personal Medication Importation Enforcement Data 2024-2025. CBP. 2025.
- Interpol. Counterfeit Pharmaceutical Seizure Statistics 2025. Interpol Pharmaceutical Crime Programme. 2025.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Mounjaro, Zepbound, and Trulicity are registered trademarks of Eli Lilly and Company. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. Costco, Shoppers Drug Mart, and Rexall are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →